In Singapore, IgA Nephropathy (also known as Berger’s Disease) remains one of the most common forms of glomerulonephritis, a condition where the filters of the kidneys become inflamed. Because this condition can progress silently over several years, early intervention and a robust management plan are essential for Singaporeans looking to protect their long-term renal function.
In this article, we examine the clinical landscape of IgA nephropathy treatment, the typical costs involved in the Singapore healthcare system, and how you can access specialist care.
Back to main channel: Chronic Kidney Disease Management
Schedule a consultation with a Nephrologist
Understanding IgA Nephropathy
IgA Nephropathy is particularly prevalent among Asians. It often presents through “bubbly” or foamy urine (proteinuria) or visible blood in the urine, especially following a respiratory infection. The primary goal of any treatment plan is to reduce the amount of protein leaking into the urine and to maintain a stable Estimated Glomerular Filtration Rate (eGFR).
IgA Nephropathy Treatment Options
While there is currently no cure for IgA Nephropathy, treatment focuses on slowing disease progression, managing symptoms and protecting kidney function. Nephrologists typically employ a combination of the following therapies based on the severity of the condition:
1. Blood Pressure and Protein Management
The foundation of treatment involves ACE Inhibitors or Angiotensin Receptor Blockers (ARBs). These medications do more than just manage hypertension; they reduce the pressure within the kidney filters, which helps to lower protein leakage and slow down scarring.
2. SGLT2 Inhibitors (e.g. Dapagliflozin)
SGLT2 inhibitors were originally developed to treat diabetes, but they are now part of international guideline-based care for chronic kidney disease, including IgA nephropathy. Studies show that these medications help protect kidney function in both diabetic and non-diabetic patients by reducing pressure within the kidney filters, lowering proteinuria, and slowing the decline in eGFR. They are increasingly used in many countries, including Singapore, as part of modern supportive therapy for IgA nephropathy.
3. Immunosuppressants and Corticosteroids
For patients at high risk of rapid progression, specialists may prescribe corticosteroids (like Prednisolone) or other immunosuppressive agents. These drugs aim to calm the overactive immune response that causes the IgA deposits to damage the kidneys.
4. Targeted Therapies
Newer, targeted release formulations of budesonide are now becoming available in Singapore. These are designed to release the medication in the gut, where the abnormal IgA production often begins, potentially reducing the systemic side effects associated with traditional steroids.
In Singapore, IgA Nephropathy (also known as Berger’s Disease) remains one of the most common forms of glomerulonephritis, a condition where the filters of the kidneys become inflamed. Because this condition can progress silently over several years, early intervention and a robust management plan are essential for Singaporeans looking to protect long-term renal function.
This article examines the clinical landscape of IgA nephropathy treatment, the typical financial considerations in the Singapore healthcare system, and how you can access specialist care.
Cost Of IgA Nephropathy Treatment
The financial commitments for managing IgA Nephropathy in Singapore are influenced by several factors, including the clinical stage of the disease, the specific medications prescribed, and whether care is sought in a public or private medical facility.
Proactive management during the early phases—focused on oral medications and consistent clinical check-ups—is relatively sustainable for most residents, particularly when leveraged against available government subsidies. In contrast, the economic requirements increase substantially if the condition advances to a stage requiring more intensive interventions such as regular dialysis or a kidney transplant.
The Singaporean healthcare framework provides a safety net through the national kidney care infrastructure. This system includes subsidised dialysis services and specialised chronic disease management programmes designed to lower the personal cash expenditure for those facing end-stage renal failure. However, patients should also account for secondary expenses, including laboratory investigations and specialist consultation fees. It is highly recommended to engage with a healthcare provider to explore all available financial aid and subsidy schemes.
Learn more: Kidney Biopsy Cost Singapore vs Malaysia: A Comprehensive Comparison for Patients
Specialists You May Consider
Choosing the right nephrologist is the first step toward effective management. Below are some practitioners you may consider who can provide advanced care:
[SG] Featured Doctor
Featured Story
For enquiries or for an introduction to a specialist, contact us below.
Frequently Asked Questions (FAQs)
Is IgA Nephropathy curable?
There is currently no absolute cure that eliminates the condition entirely. However, with appropriate treatment, many patients can achieve “remission” where protein levels remain low and kidney function stays stable for many decades.
Can I use MediSave for my treatments?
Yes, IgA Nephropathy is covered under the Chronic Disease Management Programme (CDMP). Singaporeans can use MediSave to offset the costs of outpatient consultations and medications, subject to annual limits and co-payment rules.
Will I eventually need dialysis?
Not necessarily. Many patients who receive early diagnosis and adhere to their medication and lifestyle plans never reach end-stage renal failure. The goal of treatment is to prevent the need for dialysis or a transplant.
Are there specific diet restrictions I should follow?
Generally, a low-sodium (less salt) diet is recommended to manage blood pressure. Depending on your kidney function stage, your specialist may also advise you to moderate your protein intake or limit certain minerals like potassium and phosphate.